Distinct renal injury in early atherosclerosis and renovascular disease
- PMID: 12196346
- DOI: 10.1161/01.cir.0000027105.02327.48
Distinct renal injury in early atherosclerosis and renovascular disease
Abstract
Background: Atherosclerotic renovascular disease may augment deterioration of renal function and ischemic nephropathy compared with other causes of renal artery stenosis (RAS), but the underlying mechanisms remain unclear. This study was designed to test the hypothesis that concurrent early atherosclerosis and hypoperfusion might have greater early deleterious effects on the function and structure of the stenotic kidney.
Methods and results: Regional renal hemodynamics and function at baseline and during vasoactive challenge (acetylcholine or sodium nitroprusside) were quantified in vivo in pigs by electron-beam computed tomography after a 12-week normal (n=7) or hypercholesterolemic (HC, n=7) diet, RAS (n=6), or concurrent HC and a similar degree of RAS (HC+RAS, n=7). Flash-frozen renal tissue was studied ex vivo. Basal cortical perfusion and single-kidney glomerular filtration rate (GFR) were decreased similarly in the stenotic RAS and HC+RAS kidneys, but tubular fluid reabsorption was markedly impaired only in HC+RAS. Perfusion responses to challenge were similarly blunted in the experimental groups. Stimulated GFR increased in normal, HC, and RAS (38.3+/-3.6%, 36.4+/-7.6%, and 60.4+/-9.3%, respectively, P<0.05), but not in HC+RAS (6.5+/-15.1%). These functional abnormalities in HC+RAS were accompanied by augmented perivascular, tubulointerstitial, and glomerular fibrosclerosis, inflammation, systemic and tissue oxidative stress, and tubular expression of nuclear factor-kappaB and inducible nitric oxide synthase.
Conclusions: Early chronic HC+RAS imposes distinct detrimental effects on renal function and structure in vivo and in vitro, evident primarily in the tubular and glomerular compartments. Increased oxidative stress may be involved in the proinflammatory and progrowth changes observed in the stenotic HC+RAS kidney, which might potentially facilitate the clinically observed progression to end-stage renal disease.
Similar articles
-
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1295-301. doi: 10.1161/01.ATV.0000077477.40824.52. Epub 2003 May 15. Arterioscler Thromb Vasc Biol. 2003. PMID: 12750121
-
Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia.J Am Soc Nephrol. 2005 Apr;16(4):1005-12. doi: 10.1681/ASN.2004080674. Epub 2005 Feb 16. J Am Soc Nephrol. 2005. PMID: 15716331
-
Combination of hypercholesterolemia and hypertension augments renal function abnormalities.Hypertension. 2001 Feb;37(2 Pt 2):774-80. doi: 10.1161/01.hyp.37.2.774. Hypertension. 2001. PMID: 11230372
-
Angioplasty of the renal artery: antihypertensive and renal effects.J Nephrol. 2000 Nov-Dec;13 Suppl 3:S28-33. J Nephrol. 2000. PMID: 11132030 Review.
-
Renal artery stenosis: a common, treatable cause of renal failure?Annu Rev Med. 2001;52:421-42. doi: 10.1146/annurev.med.52.1.421. Annu Rev Med. 2001. PMID: 11160787 Review.
Cited by
-
Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients.Nephrol Dial Transplant. 2017 May 1;32(5):800-807. doi: 10.1093/ndt/gfw077. Nephrol Dial Transplant. 2017. PMID: 27190371 Free PMC article.
-
Gained in translation: protective paradigms for the poststenotic kidney.Hypertension. 2015 May;65(5):976-82. doi: 10.1161/HYPERTENSIONAHA.114.04364. Epub 2015 Feb 23. Hypertension. 2015. PMID: 25712725 Free PMC article. Review. No abstract available.
-
Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.PLoS One. 2013 Dec 30;8(12):e83713. doi: 10.1371/journal.pone.0083713. eCollection 2013. PLoS One. 2013. PMID: 24386260 Free PMC article.
-
Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertension.Am J Physiol Renal Physiol. 2009 Oct;297(4):F981-6. doi: 10.1152/ajprenal.90757.2008. Epub 2009 Jul 29. Am J Physiol Renal Physiol. 2009. PMID: 19640896 Free PMC article.
-
Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.Am J Nephrol. 2016;43(2):74-84. doi: 10.1159/000444719. Epub 2016 Mar 2. Am J Nephrol. 2016. PMID: 26930122 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical